This Government Contract opportunity from Department Of Health And Human Services was posted on June 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Long-Read RNA Sequencing Kits for CARD iNDI Brain Sample Study
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institute on Aging, within the National Institutes of Health, intends to sole source a firm-fixed-price purchase order to Oxford Nanopore Technologies, Inc. for specialized long-read RNA sequencing consumables critical to its Center for Alzheimer’s Disease and Related Dementias’ induced Pluripotent Stem Cell Neurodegenerative Disease Initiative. The effort requires 171 Oxford Nanopore PromethION Flow Cells Packs DNA (FLO-PRO114M) and 114 cDNA-PCR Sequencing Kit V14 (SQK-PCS114) to perform large-scale RNA sequencing on 600 postmortem human brain samples, generating data to advance understanding of Alzheimer’s disease, Parkinson’s disease, and brain aging at the molecular level. These consumables are indispensable because they are the only products fully compatible with the Government’s existing Oxford Nanopore PromethION 48 sequencers, as alternative vendors’ products are designed for proprietary instruments and lack interchangeability. The flow cells must generate consensus data with a modal accuracy exceeding 99% and maintain precise form, fit, and function with the installed hardware, while the sequencing kits must function with no more than 10 ng of poly(A)+ RNA or 500 ng of total RNA and support six reactions per kit. This action is authorized under 41 U.S.C. 3304(a)(1) and implemented through FAR 6.302-1 and FAR 13.501(a), citing the absence of any other responsible source capable of meeting the Government’s exact technical and compatibility requirements. While this notice is not a formal solicitation, any responsible party may submit a capability statement by June 23, 2026, at 11:00 am EST, to challenge the sole source intent by providing clear and convincing evidence that they can supply the identical branded items or an equivalent solution fully compatible with the PromethION 48 platform. Required submissions include company details, SAM UEI, business size status, point of contact, proof of authorized distribution or manufacturing capability, technical documentation verifying compatibility, and estimated delivery timelines. Responses will be evaluated solely to determine whether competition is warranted, with the final decision on sole sourcing resting entirely at the Government’s discretion. All submissions must be sent electronically to Contracting Officer Linda Smith, and no formal contract clauses, pricing details, or packaging requirements are included as this document serves only as a pre-solic
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
Notice of Intent to Sole Source / Brand Name
Notice ID: NIH-NOI-26-PCA-NIA-01599
Department/Ind. Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier: NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTE ON AGING
Active Contract Opportunity
Notice Type
Special Notice
Original Published Date
06/11/2026
Response Date
06/23/2026, 11:00 am EST
Classification Code
6550 – In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
NAICS Code
334516 – Analytical Laboratory Instrument Manufacturing
Place of Performance
National Institute on Aging
Bethesda, MD
Description
This is a Notice of Intent to Sole Source / Brand Name notice and is not a request for competitive quotations.
The National Institutes of Health (NIH), National Institute on Aging (NIA), Center for Alzheimer’s Disease and Related Dementias (CARD), intends to negotiate and award a firm-fixed-price purchase order on a sole source basis to:
Oxford Nanopore Technologies, Inc.
101 AVENUE OF THE AMERICAS, FL 7, NEW YORK, NY 10013 USA
for the purchase of brand-name Oxford Nanopore long-read RNA sequencing consumables required to support CARD’s induced Pluripotent Stem Cell Neurodegenerative Disease Initiative (iNDI).
The Government requires the following brand-name items:
- Oxford Nanopore PromethION Flow Cells Packs DNA, Catalog No. FLO-PRO114M, Quantity 171
- Oxford Nanopore cDNA-PCR Sequencing Kit V14, Catalog No. SQK-PCS114, Quantity 114
These consumables are required for large-scale long-read RNA sequencing of 600 postmortem human brain samples to characterize gene expression and isoform diversity in the aging and neurodegenerating brain. The resulting data will support research relevant to Alzheimer’s disease, Parkinson’s disease, and the molecular biology of brain aging.
The required supplies must meet the following salient characteristics:
Flow Cells
- Must be able to generate consensus data at a modal accuracy above 99%
- Must be compatible with Government-owned Oxford Nanopore PromethION 48 sequencers in form, fit, and function
cDNA-PCR Sequencing Kit
- Must provide cDNA-PCR Sequencing Kit to prepare cDNA for nanopore sequencing
- Must require no more than 10 ng poly(A)+ RNA or 500 ng total RNA as starting material
- Must provide for 6 reactions
The Government’s minimum need is for brand-name Oxford Nanopore consumables because the National Institute on Aging currently operates Government-owned Oxford Nanopore PromethION 48 sequencers, and the required consumables must be fully compatible with that installed platform. The identified Oxford Nanopore flow cells and sequencing kits are proprietary products specifically designed for use with the PromethION 48 system. Other manufacturers’ sequencing consumables are designed for their own proprietary instruments and are not interchangeable with the Government’s existing Oxford Nanopore equipment.
The statutory authority for this acquisition is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements, and pursuant to FAR 13.501(a).
This notice is not a formal solicitation. However, any responsible source that believes it can provide the required brand-name Oxford Nanopore products or can otherwise meet the Government’s requirement without compromising compatibility with the existing PromethION 48 platform, may submit a capability statement for consideration.
Interested parties must submit clear and convincing documentation demonstrating their capability to provide the exact required items or an authorized source for those items. Responses must include, at a minimum:
- Company name, SAM UEI, and business size status
- Point of contact information
- Evidence of ability to provide the exact brand-name items identified above, including manufacturer authorization if applicable
- Technical documentation demonstrating compatibility with the Government-owned Oxford Nanopore PromethION 48 sequencers
- Delivery capability and estimated lead time
Responses must be received by the closing date and time of this notice and shall be submitted electronically to:
Contracting Officer: Linda Smith
Email: linda.smith2@nih.gov
All responses received by the due date will be reviewed solely for the purpose of determining whether to conduct a competitive procurement or proceed with the intended sole source award. A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government.
No solicitation package is available.
Attachments/Links
None
Contact Information
Primary Point of Contact:
Linda Smith, Contracting Officer, linda.smith2@nih.gov
Secondary Point of Contact:
Danielle Tines (c), Procurement Technician, danielle.tines@nih.gov
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
